Compare prices and print coupons for Januvia and other drugs at CVS, Walgreens, and other pharmacies. Prices start at $44.18 This statistic displays price disparities for Merck & Co.'s pharmaceutical product Januvia as of May 2026. At that time, Januvia cost *** U.S. dollars for a package of ** pills in the U.S … Compare prices and print coupons for Sitagliptin (Januvia) and other drugs at CVS, Walgreens, and other pharmacies. Prices start at $44.18 Compare Januvia prices, print discount coupons, find manufacturer promotions, copay cards and patient assistance programs. Key Takeaways January 1, 2025, marked significant brand drug price changes, with 590 adjustments, predominantly increases, and only 7 decreases. Notable drugs like Biktarvy, Ozempic, and Hemlibra saw price hikes, while Januvia experienced a 42% decrease. HHS is negotiating prices for several drugs under Medicare Part D, with some expected to see substantial future reductions. The economic … For any selected drugs for which CMS and participating drug companies have agreed upon negotiated prices under the Medicare Drug Price Negotiation Program, which the statute refers to as maximum fair prices (MFPs) the file also contains the single negotiated price for a 30-day equivalent supply of each selected drug, NDC-9 per unit price, and … The 2025 percent change in price for all products was approximately +4%, remaining consistent with the 2024 average. Among products analyzed, Pfizer's Atgam experienced the largest price increase at +15%. In contrast, significant price decreases were observed for Boehringer Ingelheim's Atrovent (-35%) and Merck's Januvia and Janumet/Janumet XR (-42.4%). Notably, Januvia is among the ten … How much does sitagliptin (januvia) cost? $10-$500 without insurance, $5-$60 with insurance. Full cost breakdown, insurance coverage, and how to save. Pharmaceutical pricing updates: Merck reduces diabetes drug WAC up to 40%, GSK caps respiratory inhalers at $35. Critical inventory management tips for pharmacies. Januvia remains a dominant player in the DPP-4 inhibitor segment, with steady sales expected through 2028, despite increasing competition. Price stability is projected overall, tempered by patent expiry and generics, especially in emerging markets. Companies should monitor regulatory policies and competitive developments for strategic positioning. Medicare coverage and pricing details for Januvia. Learn more about Medicare prescription drug plans and savings with GoodRx. Medicare Negotiations for Lower Drug Prices Explained: Januvia Thanks to President Biden and Democrats in Congress, Medicare is currently negotiating lower prices for the first 10 drugs selected for the Negotiation Program, and will negotiate lower prices for more drugs each year. By 2030, up to 80 drugs will have lower negotiated prices. One of the first ten drugs selected for negotiation is … Lower drug prices would firmly allow me to rest more often and hopefully help me transition from working full time to working part time. Without Januvia, my diabetes will get out of control. Lastly, drugs don't work if people can't afford them. Upcoming 340B Price Changes 🚨 Starting July 1, 2025, the 340B ceiling prices for Janumet, Januvia, and Spiriva will increase due to a significant decrease in their list prices. This shift is a … One of the first ten drugs selected for negotiation is Januvia, a drug used to treat type 2 diabetes, manufactured by Merck. Thanks to the Biden-Harris administration, the price drug companies charge for Januvia will drop from $527 to a maximum of $113 for a 30-day supply, a $414 or 79 percent price decrease. Januvia has made billions of dollars in revenue, and big drug companies like Merck … Medicare drug price negotiations: Here's a savings breakdown The savings range from 79% for Januvia, used to manage diabetes, to 38% for Imbruvica, which is used to treat blood cancers. Ask PharmacyChecker: Q: Merck Lowered the Price of Januvia—Insurers Dropped It from Formularies A: In a move that should have been great news for patients, Merck significantly reduced the price of its blockbuster diabetes drug, Januvia (sitagliptin). However, instead of benefiting from the savings, many insured patients are discovering that their insurance plans no longer cover it. Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and state caps, along with manufacturer programs, are helping reduce out-of-pocket insulin costs for many patients. Health Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations The savings range from 79% for Januvia, used to manage diabetes, to 38% for Imbruvica … Januvia is used to treat type 2 diabetes. Find out about cost, financial and insurance assistance, and more. Januvia isn't likely to make a huge dent in Merck's overall financial health, though. The company reported more than $16 billion in sales during the first half of the year, thanks in part to a 16% increase in sales of its cancer blockbuster Keytruda. Januvia, by comparison, accounts for about 5% of total sales. Read ASCP's post about the ten medications and their selection. The negotiated price discounts range from 38-79 percent. Januvia saw the greatest drop from $527 to $113 for a 30-day supply; a 79 percent decrease. According to HHS' press release, patients are expected to save $1.5 billion in out-of-pockets costs in 2026 alone. —Inflation Reduction Act Research Series— Januvia: Medicare Enrollee Use and Spending This Fact Sheet provides information on Januvia, one of the 10 drugs selected for the first cycle of Medicare drug price negotiations. Januvia (active ingredient sitagliptin) is a small molecule drug used to treat diabetes. About 28 percent of Medicare enrollees have diabetes, which also increases their … 2. Brand price trends over time To help contextualize brand name drug list price increase behavior, we find it beneficial to review past trends. In comparison to the data from prior months of January, this year's net (combined increases and decreases) January price changes seem to line up more with 2023 than 2024. Lower Medicare-negotiated prices for 10 drugs like Eliquis ($231/month) and Januvia ($113/month) took effect January 1, 2026. Merck has announced plans to reduce WAC prices on Januvia, Janumet and Janumet XR effective Jan. 1, 2025. That means any inventory on your shelves on Dec. 31 will lose up to 40 percent of its value overnight and you won't be able to recoup the loss. To avoid unnecessary financial loss on Januvia, Janumet and Janumet XR inventory, we recommend you return any excess inventory on these products … The Biden-Harris Administration's Inflation Reduction Act—also known as the new prescription drug law—expands Medicare benefits, lowers prescription drug costs, and, for the first time ever, allows Medicare to directly negotiate with drug companies to lower the prices for certain high-cost prescription drugs. How much does Januvia cost with Medicare? Key takeaways CMS has renegotiated the cost of Jenuvia for 2026, significantly lowering its list price. Prices Slashed on 10 Blockbuster Drugs For Medicare Patients! Blockbuster drugs like Januvia and Jardiance have been busting Medicare's budget. Now the government has negotiated big price reductions! Americans pay more than the people in other countries when it comes to prescription drugs. Without insurance, 30 tablets of brand-name Januvia 100 mg cost an average of $ 562.61. (This is a 30-day supply for most people.) However, the exact price of your prescription will depend on factors such as your pharmacy and dosage. Here are the average retail prices for common quantities and doses of brand-name Januvia and generic sitagliptin. January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including Ozempic, drugs for HIV, cancer and many others. Januvia (sitagliptin) is a medication for type 2 diabetes. Along with diet and exercise, it can help lower blood sugar levels. Medicare Part D will generally cover prescription drugs, like Januvia. —Inflation Reduction Act Research Series— Januvia: Medicare Enrollee Use and Spending This Fact Sheet provides information on Januvia, one of the 10 drugs selected for the first cycle of Medicare drug price negotiations. Januvia (active ingredient sitagliptin) is a small molecule drug used to treat diabetes. About 28 percent of Medicare enrollees have diabetes, which also increases their … Januvia is a prescription drug used to help treat type 2 diabetes in adults. Learn how to find savings, lower long-term costs, and more. The Biden administration said Thursday that it had reached an agreement with drugmakers to lower prices on the 10 costliest prescription drugs under Medicare. The over 250 drug hikes represent an increase from Dec. 29 last year when drugmakers unveiled plans to raise prices on more than 140 brands of drugs. How Much Does Januvia Cost in 2026, and Is the Generic Worth It? Brand Januvia (sitagliptin) carries a list price around $527 per month. Following patent settlement agreements, generic sitagliptin from multiple manufacturers began entering US pharmacies in May 2026, with GoodRx coupon prices as low as $110 for a 30-day supply. Read ASCP's post about the ten medications and their selection. The negotiated price discounts range from 38-79 percent. Januvia saw the greatest drop from $527 to $113 for a 30-day supply; a 79 percent decrease. According to HHS' press release, patients are expected to save $1.5 billion in out-of-pockets costs in 2026 alone. Januvia (sitagliptin) is a prescription medication that helps lower blood sugar in adults with Type 2 diabetes. It works best when you also follow a balanced diet and exercise regularly. It belongs to the drug class called dipeptidyl peptidase-4 (DPP-4) inhibitors, or gliptins. Januvia (sitagliptin) comes as a tablet you take by mouth once a day. Side effects include stuffy or runny nose and … The price of Januvia, used by 869,000 Medicare Part D enrollees, has increased 275% since it was introduced in 2006. Other drug price measures from the Inflation Reduction Act are rolling out.
